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Introduction {#sec1}
============

Multiple epidermal stem cell subpopulations in adult mouse skin have been identified over the last decade ([@bib34], [@bib59]). Although they tend to be competent to give rise to all the different epidermal lineages following transplantation, wounding, or genetic modification, under steady-state conditions, they maintain the epidermis in a compartmentalized manner ([@bib52], [@bib63]). Stem cells in the lower pilosebaceous unit (PSU) comprising the hair bulge and germ (responsible for hair regeneration) express *Krt19*, *CD34*, *Lgr5*, and *Gli1* ([@bib8], [@bib11], [@bib29]). Stem cells in the upper PSU, consisting of the hair follicle (HF) isthmus, junctional zone, infundibulum, and sebaceous gland (SG), express *Lrig1*, *Lgr6*, and *Plet1* ([@bib30], [@bib51], [@bib52], [@bib58]). Previous studies have identified *Lgr6*-expressing cells in the interfollicular epidermis (IFE) ([@bib38], [@bib52]) and a recent study has shown that they have stem cell characteristics ([@bib22]).

The Wnt pathway plays a crucial role in epidermal development, homeostasis, and cancer ([@bib9], [@bib39], [@bib62]). β-Catenin activation is required for HF morphogenesis during embryonic development and for the growth phase of the hair growth cycle in adult skin ([@bib28], [@bib40], [@bib42], [@bib49]). Recent work suggests that canonical Wnt signaling is also required for IFE stem cell activation during adult homeostasis, as loss of β-catenin in this compartment causes decreased proliferation of basal layer keratinocytes and IFE thinning ([@bib16], [@bib40]). In adult skin, transient epidermal activation of β-catenin induces ectopic HFs in SG, HF, and IFE ([@bib4], [@bib41], [@bib57]). However, the different regions of the skin exhibit differential sensitivity to β-catenin, with SG being most sensitive and the HF bulge being highly insensitive ([@bib4], [@bib18], [@bib57]).

In addition to its role in normal epidermis, deregulated Wnt signaling is a feature of epidermal tumors ([@bib32], [@bib62]). In human skin, oncogenic activation of β-catenin occurs in HF tumors known as pilomatricomas ([@bib13]), while mutations in the LEF1 transcription factor that prevent binding of β-catenin are associated with SG tumors ([@bib60]). Consistent with the human studies, in mouse, sustained activation of β-catenin in all stem cell compartments that express keratin 14 (*Krt14*) results in pilomatricomas and trichofolliculomas ([@bib23], [@bib41], [@bib61], [@bib62]), while expression of *ΔNLef1* results in SG tumors ([@bib49], [@bib50]). In addition, epidermal deletion of β-catenin causes regression of squamous cell carcinomas (SCCs) ([@bib7], [@bib41], [@bib44]). Formation of basal cell carcinomas (BCCs) has also been shown to be dependent on β-catenin activation, either in response to activating mutations in the Hedgehog signaling pathway ([@bib66], [@bib67]) or in the absence of vitamin D receptor signaling ([@bib53]).

The differential sensitivity of different regions of the epidermis to forming new HFs on transient β-catenin activation and the diversity of epidermal tumor types associated with oncogenic β-catenin mutations raise the question of whether different epidermal stem cell populations exhibit different responses to β-catenin. To investigate this, we activated β-catenin in LGR5^+^, LGR6^+^, and LRIG1^+^ stem cells and examined the consequences. Our results show that the outcome of β-catenin activation is specified by the compartmental origin of the initiating epidermal stem cells and correlates with distinct changes in the underlying dermis.

Results {#sec2}
=======

Expression of *Lgr5*, *Lgr6*, and *Lrig1* in Adult Mouse Epidermis {#sec2.1}
------------------------------------------------------------------

We used *Lgr5EGFPiresCreER*^T2^ (*Lgr5* KI), *Lgr6EGFPiresCreER*^T2^ (*Lgr6* KI), and *Lrig1EGFPiresCreER*^T2^ (*Lrig1* KI) mouse lines to target each stem cell compartment ([Figure 1](#fig1){ref-type="fig"}A). We collected tail skin from adult mice and analyzed epidermal EGFP expression to confirm the location of cells expressing each marker. As reported previously, *Lgr5*-EGFP^+^ cells were found in the cycling portion of both telogen and anagen HFs ([Figure 1](#fig1){ref-type="fig"}B) ([@bib29]). *Lrig1*-EGFP^+^ cells were mainly found in the HF junctional zone ([Figure 1](#fig1){ref-type="fig"}C) but were also found along the periphery of the SG, in the late telogen hair germ, and in the anagen hair bulb and outer root sheath, in agreement with previous publications ([@bib30], [@bib52]). *Lgr6*-EGFP expression in the HF isthmus ([@bib58]), SG, and lower HF ([Figure 1](#fig1){ref-type="fig"}D) was also confirmed ([@bib38], [@bib52]). Significant overlap between LRIG1 and *Lgr5*-EGFP expression was found in the lower HF, particularly in anagen follicles ([Figure 1](#fig1){ref-type="fig"}B). LRIG1 was co-expressed with *Lgr6*-EGFP at the junction between the isthmus and the junctional zone of the upper HF and the periphery of the SG ([Figure 1](#fig1){ref-type="fig"}E).

Scattered *Lgr6*-EGFP^+^ cells were also found in tail IFE ([Figure 1](#fig1){ref-type="fig"}D). Mouse tail IFE contains two distinct lineages of keratinocytes that form the parakeratotic scales and orthokeratotic interscales ([@bib24]). Immunostaining for the interscale markers K10 and Filaggrin (FLG) ([@bib24]) established that *Lgr6*-EGFP^+^ IFE cells were largely confined to the interscale IFE and absent from the scale IFE ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B).

For genetic lineage tracing ([@bib33]), we bred KI mice with mice carrying the *R26R-tdTomato* reporter ([Figure 1](#fig1){ref-type="fig"}F). As a control for leakiness of the CreER constructs, some mice were treated with acetone in the absence of 4-hydroxy-tamoxifen (4-OHT) ([Figure S2](#mmc1){ref-type="supplementary-material"}). In acetone-treated *Lgr5* KI/*R26R-tdTomato* mice, patches of tdTomato^+^ cells were detected in the lower HF in the absence of 4-OHT ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Some leakiness was observed in hair germ, junctional zone, infundibulum, and sebaceous duct of acetone-treated *Lrig1* KI/*R26R-tdTomato* control mice ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Acetone-only-treated *Lgr6* KI/*R26R-tdTomato* mice showed very little activation of Cre ([Figure S2](#mmc1){ref-type="supplementary-material"}C). Overall, the leakiness was minimal and specific to the expected regions of Cre expression.

When *Lgr5* KI/*R26R-tdTomato* mice were treated with one dose of 4-OHT and examined 2 weeks later, tdTomato^+^ cells were found in the hair germ and bulge ([Figure 1](#fig1){ref-type="fig"}G), as reported previously ([@bib29]). In *Lrig1* KI/*R26R-tdTomato* mice, tdTomato^+^ cells were present in the lower SG, HF junctional zone, and infundibulum (upper PSU), as well as in the hair germ ([Figure 1](#fig1){ref-type="fig"}H), again confirming previous observations ([@bib52]). In contrast, the progeny of LGR6^+^ stem cells contributed to the upper HF, SG, and IFE ([Figure 1](#fig1){ref-type="fig"}I), confirming the results for back skin previously obtained by [@bib58]. In the tail IFE, tdTomato^+^ progeny of *Lgr6*-EGFP^+^ cells were largely confined to the interscale IFE, which expresses keratin 2 (K2) in addition to K10 and Filaggrin ([Figure S1](#mmc1){ref-type="supplementary-material"}D) ([@bib24]), but absent from the K31^+^ scale IFE ([Figure S1](#mmc1){ref-type="supplementary-material"}E). tdTomato^+^ progeny of *Lgr6*-expressing cells were present in all IFE layers and were readily detectable even 6 months after 4-OHT treatment ([Figures S1](#mmc1){ref-type="supplementary-material"}D and S1F), suggesting that LGR6 marks interscale IFE stem cells.

These results confirm previous observations that LGR5, LGR6, and LRIG1 are markers of distinct epidermal subpopulations. In addition, they establish LGR6 as a marker to distinguish interscale from scale stem cells.

Stem Cell Origins of Ectopic Hair Follicles {#sec2.2}
-------------------------------------------

To study the contribution of each stem cell population to ectopic HF formation, we bred KI mice with ΔK5ΔNβ-cateninER^t^ (ΔK5β-catER) transgenic mice ([@bib4]) carrying the *R26R-tdTomato* reporter ([Figure 2](#fig2){ref-type="fig"}A). Adult mice were treated with one dose of 4-OHT to simultaneously induce Cre and ectopic HF formation ([Figure 2](#fig2){ref-type="fig"}B). Tissue was collected 1 or 2 weeks following 4-OHT application, by which time ectopic HF formation was evident ([Figures 2](#fig2){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}B). Activation of the ΔK5β-catER transgene stimulated anagen of existing HFs and induced conversion of SGs into ectopic HFs ([Figure S3](#mmc1){ref-type="supplementary-material"}). Cells in ectopic HFs and the base of anagen HFs expressed CDP, an inner root sheath/hair bulb marker, as reported previously ([Figures 2](#fig2){ref-type="fig"}C--2E) ([@bib4], [@bib41]). CDP expression was not detected in SGs of 4-OHT-treated mice lacking the ΔK5β-catER transgene, but CDP was expressed in some cells of the hair germ ([Figure S4](#mmc1){ref-type="supplementary-material"}A).

In 4-OHT-treated *Lgr5* KI/*R26R-tdTomato*/ΔK5β-catER mice, robust tdTomato labeling was detected in the lower hair bulge and early anagen bulbs ([Figure 2](#fig2){ref-type="fig"}C). tdTomato^+^ progeny of *Lgr5*-expressing cells were present in ∼11% of ectopic HFs ([Figure 2](#fig2){ref-type="fig"}F), where they were confined to the inner cell layers ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Some EGFP^+^ cells were detected in ectopic HFs, consistent with *Lgr5* being a Wnt target gene ([Figure 2](#fig2){ref-type="fig"}G).

Over 90% of ectopic HFs in *Lrig1* KI/*R26R-tdTomato*/ΔK5β-catER epidermis contained clusters of tdTomato^+^ cells ([Figures 2](#fig2){ref-type="fig"}D and 2F). Ectopic HFs were also strongly positive for *Lrig1*-EGFP ([Figure 2](#fig2){ref-type="fig"}G). Almost 100% of ectopic HFs arising from SGs in *Lgr6* KI/*R26R-tdTomato*/ΔK5β-catER mice were strongly labeled with tdTomato ([Figures 2](#fig2){ref-type="fig"}E and 2F), and *Lgr6*-EGFP^+^ cells were found in the ectopic HFs arising from the SG ([Figure 2](#fig2){ref-type="fig"}G). *Lgr6*-EGFP and LRIG1 were both expressed in ectopic HFs arising in the IFE ([Figure 2](#fig2){ref-type="fig"}I).

Although in ΔK5β-catER transgenic mice ectopic HFs arise predominantly from the SG, some ectopic HFs also form in the tail IFE ([@bib4]), even after a single dose of 4-OHT ([Figure 2](#fig2){ref-type="fig"}H). The IFE ectopic HFs were derived from LGR6^+^, but not from LRIG1^+^ or LGR5^+^ stem cells of the HF ([Figure 2](#fig2){ref-type="fig"}H; data not shown). tdTomato labeling in IFE ectopic HFs was not continuous with the PSU ([Figure 2](#fig2){ref-type="fig"}H), which supports the concept that the ectopic growths were of IFE origin, as previously reported ([@bib57]).

Collectively, these data demonstrate that ectopic HFs arising from the SG are not derived from *Lgr5*-expressing stem cells but originate from stem cell pools expressing *Lrig1* and *Lgr6* that reside at, or in close proximity to, the sites of ectopic HF formation ([Figure 2](#fig2){ref-type="fig"}J). Ectopic HFs often comprised a mixture of tdTomato-positive and negative cells ([Figures 2](#fig2){ref-type="fig"}E--2G), indicating a polyclonal origin. LGR6^+^ IFE cells contributed to ectopic HFs arising from the IFE, whereas LRIG1^+^ and LGR5^+^ HF cells did not ([Figure 2](#fig2){ref-type="fig"}J).

β-Catenin Activation in Different Stem Cell Populations Results in Different Tumor Types {#sec2.3}
----------------------------------------------------------------------------------------

To study the contribution of different stem cell populations to β-catenin-induced epidermal tumors, we generated KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mice and treated adult animals with a single dose of 4-OHT. Cre-dependent deletion of exon 3 of *Ctnnb1* (*Ctnnb1*^lox(ex3)^) results in constitutive activation of β-catenin in the respective stem cell populations and their progeny ([@bib27]) ([Figures 3](#fig3){ref-type="fig"}A and 3B). Control mice that lacked the *Ctnnb1* mutant allele did not exhibit any abnormal phenotypes ([Figures 3](#fig3){ref-type="fig"}C--3F).

*Lgr5* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mice entered anagen 2 weeks following 4-OHT application, and pilomatricomas, benign HF skin tumors ([@bib13], [@bib41], [@bib46]), developed within 4 weeks ([Figures 3](#fig3){ref-type="fig"}A--3I). The upper portions of the HF, SGs, and IFE were unaffected by the lesions arising in the lower HF ([Figures 3](#fig3){ref-type="fig"}D--3M). Eight weeks following 4-OHT application, most HFs had re-entered telogen, but pilomatricomas persisted, extending into the skin adipocyte layer ([Figures 3](#fig3){ref-type="fig"}F, 3H, and 3I; 50 PSUs scored from two mice). Mice carrying the mutant allele of *Ctnnb1* had to be killed 8 weeks following 4-OHT induction due to weight loss. The mice had developed small intestinal tumors most likely caused by 4-OHT ingestion activating the mutant allele in *Lgr5*-expressing cells of the gastrointestinal (GI) tract (data not shown) ([@bib6]).

In *Lgr5* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mutant and *Lgr5* KI/*R26R-tdTomato*/*Ctnnb1*^+/+^ control skin tdTomato^+^ cells were only present in the lower HF (bulge and hair germ) and were absent from the permanent portion of the HF ([Figures 3](#fig3){ref-type="fig"}J and 3K). No *Lgr5*-EGFP^+^ or tdTomato^+^ cells were found in the dermis ([Figures 3](#fig3){ref-type="fig"}J and 3K). Immunostaining for β-catenin and LEF1 indicated that Wnt signaling was restricted to anagen bulbs and HF tumors ([Figures 3](#fig3){ref-type="fig"}L and 3M; data not shown). HF tumors were strongly positive for the proliferation marker Ki67 ([Figure S5](#mmc1){ref-type="supplementary-material"}A) and expressed the HF differentiation markers K17 and K31 ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C).

In contrast to *Lgr5* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mice, adult *Lrig1* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mice ([Figures 4](#fig4){ref-type="fig"}A and 4B) developed a hyperplastic, highly keratinized junctional zone and a thickening of the IFE within 4 weeks following 4-OHT application ([Figures 4](#fig4){ref-type="fig"}C, 4F, and 4G). The phenotype became progressively more severe over the subsequent 6 weeks after 4-OHT treatment, affecting the entire HF ([Figures 4](#fig4){ref-type="fig"}D--4G). The lesions resembled human trichoadenomas, a rare benign follicular tumor with cornifying cysts ([@bib36], [@bib56]), with a high proportion of undifferentiated cells and an infiltrate of immune cells including neutrophils ([Figure S6](#mmc1){ref-type="supplementary-material"}A). *Lrig1* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mice had to be killed within 6 weeks of the start of the experiment, as they developed GI tumors, consistent with *Lrig1* expression in the intestinal epithelium ([@bib55], [@bib65]).

Lineage tracing revealed that at 4 weeks tdTomato^+^ cells were mostly restricted to the tumors, the upper portion of the HF and IFE ([Figures 4](#fig4){ref-type="fig"}H and 4I). In agreement with previous publications, cells positive for tdTomato and *Lrig1*-EGFP were also found in the dermis ([@bib20], [@bib24]) ([Figures 4](#fig4){ref-type="fig"}H and 4I). β-Catenin and LEF1 expression was highly upregulated in the hyperplastic HF junctional zone and tumors of *Ctnnb1* mutant skin ([Figure 4](#fig4){ref-type="fig"}J). However, nuclear β-catenin and LEF1 were not detected in the IFE or tumor stroma, suggesting a lack of significant Wnt/β-catenin activity in these compartments ([Figure 4](#fig4){ref-type="fig"}J).

Expression of K14 extended into the suprabasal layers of back skin IFE and cysts, while expression of the differentiation markers K10 and involucrin (IVL) was perturbed in the suprabasal layers ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6C), indicating abnormal terminal differentiation, as observed in human trichoadenoma ([@bib36]). Pronounced expression of cyclin D1 and Ki67 in the trichoadenoma cysts ([Figures S6](#mmc1){ref-type="supplementary-material"}D and S6E) confirmed hyperplasia, again consistent with the human lesions ([@bib36], [@bib56]).

Within 4 weeks of 4-OHT treatment ([Figures 5](#fig5){ref-type="fig"}A and 5B), *Lgr6* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mutant skin developed ectopic HFs from the SG and IFE and exhibited expansion of the upper portion of the HF ([Figures 5](#fig5){ref-type="fig"}C, 5D, 5H--5J, and 5L). By 12 weeks, cysts had formed in the SG and upper and lower HF ([Figures 5](#fig5){ref-type="fig"}F--5L). The IFE of *Lgr6* mutant skin progressively developed irregular invaginations into the underlying dermis resembling the epithelial compartment of a benign human skin lesion called dermatofibroma (or benign fibrous histiocytoma) ([Figures 5](#fig5){ref-type="fig"}G, 5I, and 5L). Dermatofibroma is characterized by pronounced epidermal hyperplasia and occasional HF budding that mimics superficial BCCs ([@bib68]). At four weeks, the HF outgrowths in mouse skin resembled embryonic hair placodes and hair germs ([Figures 5](#fig5){ref-type="fig"}D and 5E). Some developed into small HFs with associated SGs ([Figure S7](#mmc1){ref-type="supplementary-material"}A) but progressed into disorganized lesions ([Figure 5](#fig5){ref-type="fig"}G).

Expression of *Lgr6*-EGFP and tdTomato was compartmentalized in *Ctnnb1* mutant skin, with cells positive for either or both markers being present in the IFE and hyperplastic HF junctional zone as well as ectopic HFs arising from the SG ([Figure 5](#fig5){ref-type="fig"}M). In *Ctnnb1* mutant skin, β-catenin, LEF1, and cyclin D1 expression was highly upregulated in cells in tumors and ectopic HFs ([Figures 5](#fig5){ref-type="fig"}N and [S7](#mmc1){ref-type="supplementary-material"}B). IFE dysplasias were also strongly positive for the proliferation marker Ki67 and showed defects in differentiation ([Figures S7](#mmc1){ref-type="supplementary-material"}C and S7D). Infundibular cysts and HF buds arising from the IFE were positive for the HF lineage marker K17 ([Figure S7](#mmc1){ref-type="supplementary-material"}E).

These experiments show that sustained activation of β-catenin in different stem cell compartments results in tumors that differ in location and type.

Distinct Dermal Responses to Compartmentalized Stabilization of Epidermal β-Catenin {#sec2.4}
-----------------------------------------------------------------------------------

Sustained activation of β-catenin throughout the basal layer of adult epidermis reprograms the underlying dermis to a neonatal state, characterized by an increase in fibroblast density and extensive extracellular matrix (ECM) remodeling ([@bib17]). To discover whether, in addition to inducing different types of tumors, β-catenin activation in different stem cell subpopulations had different effects on the dermis, we first evaluated skin for fibroblast density by labeling for vimentin and for ECM remodeling by labeling for CD44 and staining with Herovici. CD44 is a β-catenin target gene ([@bib64]) and the major cell-surface receptor for hyaluronic acid (hyaluronan), a key ECM component ([@bib21]). Herovici is a histochemical dye that stains highly crosslinked, mature collagen fibers pink and stains fine, immature collagen fibrils light blue ([@bib17]).

Pilomatricomas resulting from *Ctnnb1* activation in *Lgr5*-expressing stem cells were surrounded by an increased density of vimentin^+^ fibroblasts, while fibroblast density in the rest of the skin was unaffected ([Figure 6](#fig6){ref-type="fig"}A). Conversely, when stabilized β-catenin was expressed using the *Lrig1* KI and *Lgr6* KI mouse models, only the upper layers of the dermis exhibited an increased density of fibroblasts ([Figure 6](#fig6){ref-type="fig"}A).

At 4 weeks, back skin of *Lgr5* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mutant mice showed comprehensive dermal ECM remodeling and CD44 expression in the lower dermis surrounding the pilomatricomas, while the upper dermis contained only mature collagen ([Figures 6](#fig6){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}D). By 8 weeks, the entire dermis contained mature collagen (stained in pink), even though the tumors persisted ([Figure 6](#fig6){ref-type="fig"}B).

Activation of the *Ctnnb1* mutant using the *Lrig1* KI and *Lgr6* KI mouse models stimulated ECM remodeling initially only around hyperplastic sites ([Figure 6](#fig6){ref-type="fig"}B). As the tumor lesions progressed in the back skin of 4-OHT-treated *Lrig1* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mice, collagen was comprehensively remodeled and the dermis was almost entirely filled with compact immature collagen characteristic of tumor stroma ([Figure 6](#fig6){ref-type="fig"}B). CD44 expression in fibroblasts was confined to the areas surrounding the tumors but was also highly upregulated in the hyperplastic epidermal regions of the tumor itself ([Figure S6](#mmc1){ref-type="supplementary-material"}F). In *Lgr6* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ skin, the dermis underlying IFE dysplasias and surrounding upper pilosebaceous cysts stained light blue with Herovici, indicating the presence of immature collagen fibrils ([Figure 6](#fig6){ref-type="fig"}B). By 8 weeks, almost the entire dermal ECM contained immature collagen ([Figure 6](#fig6){ref-type="fig"}B). Again, CD44 expression was selectively upregulated in the fibroblasts adjacent to tumors ([Figure S7](#mmc1){ref-type="supplementary-material"}F).

We also examined dermal expression of CD45 and CD26. CD45 is expressed by infiltrating immune cells ([@bib2], [@bib37]). CD26, a T cell activation antigen also known as dipeptidyl peptidase-4 (DPP4), is upregulated in hyperproliferative epidermis and in dermal fibroblasts during wounding and chronic inflammation but is downregulated in the stroma of epidermal tumors ([@bib3], [@bib47]).

In mice carrying the *Lgr5* KI and *Ctnnb1* mutant alleles, no differences in expression of CD26 and CD45 were found at any time up to 8 weeks following 4-OHT treatment ([Figures 7](#fig7){ref-type="fig"}A and 7B). When the *Ctnnb1* activating mutation was induced in LRIG1^+^ stem cells, CD26 was highly upregulated in epidermal keratinocytes but was reduced in fibroblasts surrounding the tumors ([Figure 7](#fig7){ref-type="fig"}A). CD45^+^ cells were present in the dermis adjacent to the epidermal cysts and underlying the IFE ([Figure 7](#fig7){ref-type="fig"}B). β-Catenin stabilization in *Lgr6*-expressing stem cells in the upper epidermis stimulated dermal CD26 expression ([Figure 7](#fig7){ref-type="fig"}A) and resulted in an increase in CD45^+^ cells ([Figure 7](#fig7){ref-type="fig"}B).

To further investigate the inflammatory response ([@bib2], [@bib26]) to epidermal β-catenin activation, we examined expression of the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and the macrophage marker F4/80. NF-κB signaling and subsequent recruitment of immune cells creates a pro-tumorigenic microenvironment in skin ([@bib1], [@bib31]).

In control and *Lgr5* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mutant skin, NF-κB and F4/80 were not detectable in the dermis ([Figure 7](#fig7){ref-type="fig"}C). In contrast, skin from mice carrying the *Ctnnb1* mutant allele with the *Lgr6* KI or *Lrig1* KI had strongly elevated expression of NF-κB in both epidermis and dermis ([Figure 7](#fig7){ref-type="fig"}C). F4/80^+^ macrophages were present in regions of the tumor stroma with high NF-κB expression ([Figure 7](#fig7){ref-type="fig"}C).

In summary, the compartmentalized induction of epidermal β-catenin triggered different dermal responses, reflecting differences in the behavior of fibroblasts and immune cells. HF tumors in *Lgr5* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mutant skin arose in the absence of inflammation, while tumors initiated in the permanent portion of the epidermis of *Lgr6* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ or *Lrig1* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mice were characterized by stromal inflammation ([@bib2], [@bib26]).

Discussion {#sec3}
==========

Here, we show that different epidermal stem cell populations exhibit different responses to transient or sustained activation of Wnt/β-catenin. We identify the cells of origin of ectopic HFs and three different types of epidermal tumor. We show that different tumor types have a distinct stromal signature, and we identify the stem cell compartment that gives rise to the orthokeratotic interscale IFE in the tail.

By targeting distinct epidermal stem cell compartments in the lower (hair germ and bulge) and upper PSU (HF isthmus, junctional zone, infundibulum, and SG) and IFE, we traced the cellular origin of ectopic HFs induced by transient epidermal β-catenin activation in the SG and orthokeratotic IFE. Ectopic HFs did not originate from LGR5^+^ stem cells in the lower HF, even though they are β-catenin sensitive ([@bib29]), and LGR5^+^ cells in the new HFs arose from LGR5^-^ cells, suggesting that ectopic HFs indeed recapitulate the process of HF development, which has been proposed previously ([@bib4], [@bib41], [@bib57]). Thus, β-catenin-sensitive LGR5^+^ cells in the lower HF were not redirected to sites of ectopic HF formation in the epidermal compartments above the bulge.

In contrast, the progeny of LGR6^+^ and LRIG1^+^ epidermal stem cells robustly contributed to ectopic HFs arising from the SG. None of the new follicles were 100% tdTomato^+^, demonstrating that they were polyclonal in origin, as reported previously ([@bib57]). We conclude that β-catenin activation within the SG causes a direct lineage switch of stem cell progeny from sebocytes to HF lineages, and tissue compartmentalization is maintained ([@bib22], [@bib52]).

The progeny of LGR6^+^ stem cells have previously been traced into the IFE, SG, and upper HF, suggesting that a single pool of *Lgr6*-expressing stem cells renews the entire permanent portion of adult epidermis ([@bib58]). However, two subsequent studies identified scattered *Lgr6*-EGFP^+^ cells in multiple compartments of adult mouse back skin, including the lower HF, SG, and IFE ([Figure 1](#fig1){ref-type="fig"}D) ([@bib38], [@bib52]), and a recent study has demonstrated that LGR6^+^ cells in all these regions contribute to epidermal homeostasis ([@bib22]). We were able to show that ectopic HFs arising from the IFE are derived from *Lgr6*-expressing cells in the interscale of tail IFE ([Figures 2](#fig2){ref-type="fig"}H and 2I), strongly suggesting that LGR6^+^ cells constitute the interscale stem cell pool ([@bib24]). In contrast, the scale IFE of tail skin did not express *Lgr6* ([Figure S1](#mmc1){ref-type="supplementary-material"}). Some of the hair placodes originating from LGR6^+^ IFE matured into hair-shaft-producing HFs that had associated SGs, upon activation of the *Ctnnb1*^lox(ex3)^ mutant allele ([Figure S7](#mmc1){ref-type="supplementary-material"}A), establishing the competence of the IFE to undergo HF neogenesis in adult murine back skin.

Tumor formation was readily initiated from all the epidermal compartments in back skin upon genetic stabilization of β-catenin. Further triggers such wounding or 7,12-dimethylbenz\[α\]anthracene (DMBA)/12-O-tetradecanoylphorbol 13-acetate (TPA) treatment, as reported for expression of oncogenic K-Ras ([@bib52]), were not required. Compartmentalization was maintained, such that tumors arising from LGR5^+^ cells in the lower HF did not involve the upper HF or IFE, and tumors of LRIG1^+^ and LGR6^+^ cells in the upper HF spared the lower HF. Only in the very late stages of tumor progression was tissue integrity destroyed as a result of expansion of the tumor mass.

Deregulated Wnt signaling in skin has previously been associated with different types of tumors ([@bib32], [@bib62]). We now show that tumor type depends, at least in part, on the stem cell compartment in which β-catenin is activated. LGR5^+^ cells gave rise to pilomatricomas, while LRIG1^+^ cells formed trichoadenomas and LGR6^+^ cells formed infundibular cysts in the HF junctional zone and dermatofibromas in the IFE. Although dermatofibromas are characterized by increased fibroblast density and comprehensive ECM remodeling in the reticular dermis, it has been unclear whether these changes reflect oncogenic changes in the fibroblasts themselves or a response to changes in the epidermis ([@bib12], [@bib14]). Our study implicates the epidermis as the oncogenic target in dermatofibromas. Of note, studies have shown that some dermatofibromas resemble superficial BCCs ([@bib68]), and the β-catenin-induced dermatofibromas in our study expressed typical BCC markers such as K17 and cyclin D1 ([@bib67]). It has previously been suggested that BCCs can arise from IFE cells in response to activating mutations in the Hedgehog (Hh) signaling pathway ([@bib25], [@bib66], [@bib67]). Studies have also shown that β-catenin activation is required for progression of BCC in human and BCC-like lesions in mice ([@bib53], [@bib67]).

The oncogenic effects of β-catenin activation in LGR6^+^ stem cell subpopulations not only caused different phenotypes depending on their location (IFE, dermatofibromas; HF junctional zone, infundibular cysts) but also took longer to develop in the IFE than the HF junctional zone, as recently reported for Hh-induced BCCs ([@bib54]). It has been suggested that the IFE is resistant to Wnt/β-catenin signaling ([@bib62]), since epidermal deletion of β-catenin primarily affects the HFs and SGs ([@bib28]) and ectopic HFs only arise in the IFE following strong β-catenin activation ([@bib41], [@bib57]). However, there is recent evidence that Wnt signaling does control IFE stem cell proliferation, but its activity is tightly regulated to control the balance between self-renewal and differentiation of IFE stem cells ([@bib16], [@bib40]). This might explain the slow development of neoplastic lesions in the IFE of *Lgr6* KI mice carrying the *Ctnnb1* activating mutation.

It has previously been shown that epidermal activation of β-catenin throughout the epidermal stem cell compartment leads to reprogramming of the dermis to a neonatal state characterized by increased fibroblast density and extensive ECM remodeling ([@bib17]). The fibroblast lineages of the upper and lower dermis are responsive to epidermal β-catenin activity ([@bib20]), as is the hypodermal adipocyte layer ([@bib19]). Here, we show that genetic stabilization of β-catenin in different epidermal stem cell populations resulted in compartmentalized dermal responses. In each case, there was a local increase in fibroblast density and transient ECM remodeling.

Different stromal responses to β-catenin activation in the different stem cell compartments led to distinct stromal signatures. The influx of inflammatory cells elicited by the LRIG1^+^ compartment could reflect the expansion of the infundibulum and associated defects in the epidermal barrier ([@bib15]) or activation of β-catenin in LRIG1^+^ fibroblasts ([@bib24]). The different tumor types also had different effects on CD26 expression: CD26 expression was unchanged when LGR5^+^ cells were targeted, was upregulated on targeting of LGR6^+^ cells, and was downregulated by targeting LRIG1^+^ cells. During skin development, CD26^+^ fibroblasts reside in the papillary dermis, which provides a permissive microenvironment for HF induction ([@bib20]). Upregulation of CD26 also occurs in response to epidermal IL1α and wounding but is downregulated in the stroma of papillomas and SCCs ([@bib3]). It remains to be determined whether the upregulation of CD26 reflects a selective expansion of the upper dermal lineage.

In summary, we have shown that epidermal compartmentalization is sustained during activation of epidermal Wnt/β-catenin signaling in adult skin. Stem cells differ in their contribution to ectopic HFs, and stem cell heterogeneity leads to formation of different tumor types with different stromal composition. Our study highlights the functional significance of the different epidermal stem cell populations.

Experimental Procedures {#sec4}
=======================

Mice {#sec4.1}
----

All animal experiments were subject to institutional ethical review and performed under the terms of a UK Home Office license. *Ctnnb1*^lox(ex3)/+^, ΔK5ΔNβ-cateninER^t^, *K19CreER*^T^, *Lgr5EGFPiresCreER*^T2^, *Lgr6EGFPiresCreER*^T2^, *Lrig5EGFPiresCreER*^T2^, and *R26R-tdTomato* (Ai9 line) mice have been described previously ([@bib4], [@bib5], [@bib27], [@bib43], [@bib45], [@bib52], [@bib58]). For each condition and time point, three to five mice were treated and analyzed, unless stated otherwise. Treatment regimes are described in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Histology and Immunohistochemistry {#sec4.2}
----------------------------------

Back and tail skin was fixed overnight in 4% paraformaldehyde (Sigma) and embedded in paraffin wax. Immunohistochemistry and tail epidermal whole-mount preparation were performed as described previously ([@bib10], [@bib17], [@bib35]) and are described in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Quantification of tdTomato-Positive Ectopic HFs {#sec4.3}
-----------------------------------------------

10--25 pilosebaceous units per tail epidermal whole-mount collected from each mouse were examined for tdTomato^+^ ectopic HFs arising from the SG 2 weeks after 4-OHT application. For each mouse the proportion of pilosebaceous units containing tdTomato^+^ cells was calculated. This proportion was used to calculate the mean average ± SEM from three mice per condition. Statistical analysis was performed using the unpaired Student's t test. p values of less than 0.05 were considered statistically significant.

Quantification of Abnormal Phenotypes {#sec4.4}
-------------------------------------

Scanned H&E-stained sections of 25 back skin pilosebaceous units per mouse were examined using Aperio ImageScope software (Leica) for abnormalities in epidermal subcompartments (IFE, SG, upper HF: infundibulum, junctional zone and isthmus; lower HF: bulge and hair germ), as described previously ([@bib66]). IFE phenotypes were classified as normal, hyperplastic (increased numbers of cells), dysplastic (abnormal cell morphology) ([@bib66]), or dermatofibroma-positive. SG were scored as normal or abnormal (ectopic HFs and cysts). HF phenotypes were scored in the lower HF (bulge and hair germ) as normal (anagen versus telogen) following standard histological guidelines ([@bib48]), cystic (absence of intact hair shaft), or pilomatricoma positive. The proportion of lesions for each condition and the proportions of the different types of lesions per epidermal subcompartment were calculated from each mouse. This proportion was used to calculate the mean average ± SEM from three to five mice per condition and time point, unless stated otherwise.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures and Figures S1--S7Document S2. Article plus Supplemental Information
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![Epidermal Expression and Lineage Tracing of *Lgr5*, *Lrig1*, and *Lgr6* during Adult Homeostasis\
(A) Schematic diagram of stem cell marker expression in the epidermis.\
(B--E) Detection of *Lgr5*-EGFP (green in B), *Lrig1*-EGFP (green in C), *Lgr6*-EGFP (green in D and E), and K14 (red) or LRIG1 (red) in tail epidermal whole mounts of the respective adult KI mice. Whole mounts were counterstained with phalloidin to label F-actin (blue). Single-color images are shown for some markers in grayscale.\
(F) Schematic representation of the genetic elements for lineage tracing during adult homeostasis (control) and the experimental setup.\
(G--I) Tail epidermal whole mounts of *Lgr5* KI/*R26R-tdTomato* (G), *Lrig1* KI/*R26R-tdTomato* (H), and *Lgr6* KI/*R26R-tdTomato* (I) mice collected 2 weeks after 4-OHT treatment, stained with anti-tdTomato (red), and counterstained with DAPI to label nuclei (blue). Single-color images for tdTomato are shown in grayscale.\
Bu, bulge; DP, dermal papilla; HG, hair germ; IFE, interfollicular epidermis; JZ/IS, junctional zone/isthmus; INF, infundibulum; SG, sebaceous gland. Dashed lines demarcate HF, SG, and ectopic HFs. Scale bars, 100 μm.](gr1){#fig1}

![Lineage Tracing of Ectopic Hair Follicles\
(A and B) Schematic representation of the genetic elements for lineage tracing (A) and experimental setup (B).\
(C--E and G--I) Tail epidermal whole mounts collected 2 weeks after 4-OHT treatment and stained with anti-tdTomato, anti-CDP, and anti-GFP, as indicated. Boxed regions in (C)--(E) are also shown at higher magnification. (C and G) *Lgr5* KI/*R26R-tdTomato*/ΔK5ΔNβ-cateninER; (D and G) *Lrig1* KI/*R26R-tdTomato*/ΔK5ΔNβ-cateninER; (E, G, H, and I) *Lgr6* KI/*R26R-tdTomato*/ΔK5ΔNβ-cateninER. Whole mounts were counterstained with DAPI to label nuclei or with phalloidin to label F-actin (blue). Single-color images for some markers are shown in grayscale. Dashed lines demarcate HF, SG and ectopic HFs. Individual ectopic HFs are indicated with arrowheads.\
(F) % pilosebaceous units (PSUs) with tdTomato^+^ ectopic HFs (10--25 PSUs per mouse, n = 3). Data are mean ± SEM. ^∗^p \< 0.05.\
(J) Schematic showing the cellular origins of ectopic HF (eHF).\
Bu, bulge; DP, dermal papilla; HG, hair germ; IFE, interfollicular epidermis; JZ/IS, junctional zone/isthmus; INF, infundibulum; SC, stem cell. Scale bars represent 100 μm (C--E and G) and 50 μm (H and I).](gr2){#fig2}

![Oncogenic Activation of β-Catenin in LGR5^+^ Stem Cells\
(A) Schematic representation of the genetic elements for lineage tracing and β-catenin activation.\
(B) Experimental setup.\
(C--F and J--M) Back skin sections of *Lgr5* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mutant and control (Ctrl) mice 4 (C, D, J--M) and 8 weeks after 4-OHT treatment (E and F). (C--F) H&E staining. (J--M) Immunolabeled with the antibodies indicated and counterstained with DAPI to label nuclei (blue). Grayscale images of the same fields are also shown. Dashed lines denote epidermal-dermal boundaries. Insert shows higher magnification view of selected area. Scale bars, 200 μm.\
(G and H) Quantification of lesions in all epidermal subcompartments (G) and lower HF phenotypes (H). Data are means ± SD (25 PSUs scored per mouse; 4 weeks, n = 3; 8 weeks, n = 2).\
(I) Schematic of phenotype progression over time. Scale bars, 200 μm.](gr3){#fig3}

![Oncogenic Activation of β-Catenin in LRIG1^+^ Stem Cells\
(A) Schematic representation of genetic elements for lineage tracing and β-catenin activation.\
(B) Experimental setup.\
(C--E and H--J) Back skin sections of *Lrig1* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mutant and control (Ctrl) mice 4 weeks (unless stated otherwise) after 4-OHT application, stained with H&E (C--E) or antibodies to the markers indicated, with DAPI counterstain to label nuclei (blue) (H--J). Grayscale images for the same fields are also shown (H--J). Dashed lines and arrowheads denote epidermal-dermal boundaries. Inserts show higher magnification views of selected areas. Scale bars represent 200 μm, except (J.I)--(J.IV) (50 μm).\
(F) Quantification of lesions in all dorsal epidermal subcompartments with abnormalities. 25 PSUs per mouse (n = 3). Data are means ± SEM.\
(G) Schematic of phenotype progression over time.](gr4){#fig4}

![Oncogenic Activation of β-Catenin in LGR6^+^ Stem Cells\
(A) Schematic representation of genetic elements for lineage tracing and oncogenic β-catenin activation in LGR6^+^ stem cells.\
(B) Experimental setup.\
(C, D, F, G, M, and N) Back skin sections of *Lgr6* KI/*R26R-tdTomato*/*Ctnnb1*^lox(ex3)/+^ mutant and control (Ctrl) mice 4 weeks (unless stated otherwise) after 4-OHT application, stained with hematoxylin and eosin (H&E; C, D, F, and G) or antibodies to the markers indicated, with DAPI counterstain to label nuclei (blue) (M and N). Grayscale images for the same fields are also shown. Dashed lines denote epidermal-dermal boundaries. Inserts show higher magnification views of selected areas.\
(E) E15.5 sections of wild-type embryonic skin stained with hematoxylin and eosin.\
(H--K) Quantification of lesions in all dorsal epidermal subcompartments with abnormalities (H) and specific abnormalities in IFE (I), SG (J), and HF (K). 25 PSUs per mouse (n = 3). Data are means ± SEM.\
(L) Schematic of phenotype progression over time.\
Scale bars represent 200 μm, except (E) (100 μm).](gr5){#fig5}

![Differential Stromal Responses to Compartmentalized Epidermal Activation of β-Catenin\
(A and B) Back skin sections of *Ctnnb1*^lox(ex3)/+^ mutant and control (Ctrl) mice indicated, 4 weeks (unless stated otherwise) after 4-OHT application. (A) Stained with anti-K14 (green) and anti-vimentin (VIM; red), with DAPI counterstain (blue). (B) Stained with Herovici dye to visualize immature collagen (light blue) and mature collagen (pink). Dashed lines and arrowheads denote epithelial-stromal boundaries. Scale bars, 200 μm.](gr6){#fig6}

![Inflammatory Response to Compartmentalized Epidermal β-Catenin Activation\
(A--C) Back skin sections collected from *Ctnnb1*^lox(ex3)/+^ mutant and representative control (Ctrl) mice 12 (*Lgr6* KI), 8 (*Lgr5* KI), and 6 weeks (*Lrig1* KI) after 4-OHT application, stained with antibodies to the markers indicated and counterstained with DAPI (blue). Grayscale images show the same field (A) or higher-magnification views of selected areas (C). Arrows show lack of staining, and arrowheads show positive staining in the stroma. Dashed lines indicate boundary between epithelium and stroma. Scale bars, 200 μm.](gr7){#fig7}
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